Antidiabetic activity of Zn(II) complexes with a derivative of L-glutamine

Bulletin of the Chemical Society of Japan

Volumn 78, Issue 6, 2005, Pages 1077-1081

  Matsumoto, Kinuyo ^a   Yamamoto, Shuhei ^b   Yoshikawa, Yutaka ^c   Doe, Matsumi ^b   Kojima, Yoshitane ^b   Sakurai, Hiromu ^c   Hashimoto, Hiroko ^a   Kajiwara, Naemi M ^a  

^a KOBE WOMEN'S UNIVERSITY   (Japan)

^b Osaka Prefecture University   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; BLOOD; DISEASE CONTROL; FATTY ACIDS; GLUCOSE; INSULIN;

ANTIDIABETIC ACTIVITY; INSULINOMIMETIC ACTIVITY; RODENT ADIPOCYTES; SERUM;

ZINC COMPOUNDS;

ADRENALIN; ANTIDIABETIC AGENT; FATTY ACID; GLUCOSE; GLUTAMINE DERIVATIVE; GLUTAMYLMETHYLAMIDE; HEMOGLOBIN A1C; THEANINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINC COMPLEX; ZINC GAMMA GLUTAMYLMETHYLAMIDE; ZINC THEANINE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOGLOBIN DETERMINATION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; RAT; TEA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 21244451486     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.78.1077     Document Type: Article

References (37)

1. Fact Sheet No, 236 WHO Revised Sept. (2002).
2. Survey on diabetes published recently, "Ministry of Health, Labor, and Welfare," Japan (2002).
3. a) S. J. Lippard and J. M. Berg, "Principles of Bioinorganic Chemistry," University Science Books, California (1994).
4. b) J. J. R. de Silva Fransto and R. J. P. Williams, "The Biological Chemistry of the Elements," Clarendon Press, Oxford (1993).
5. c) J. A. Cowan, "Inorganic Biochemistry: An Introduction," 2nd ed, Wiley-VCH (1997).
6. A. Blostein-Fujii, R. A. DiSilvestro, D. Frid, C. Katz, and W. Malarkey, Am. J. Clin. Nutr., 66, 639 (1997).
7. L. Coulston and P. Dandona, Diabetes, 29, 665 (1980).
8. M. M. James and S. C. Charles, J. Biol. Chem., 257, 4362 (1982).
9. A. Shisheva, D. Gefel, and Y. Schechter, Diabetes, 41, 982 (1992).
10. M. D. Chen, S. J. Liou, P. Y. Lin, V. C. Yang, P. S. Alexander, and W. H. Lin, Biol. Trace Elem. Res., 61, 303 (1998).
11. R. C. Hider, R. Ejim, P. D. Taylor, R. Gale, E. Huehns, and J. B. Porter, Biochem. Pharmacol., 39, 1005 (1990).
12. Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, H. Sakurai, and Y. Kojima, Chem. Lett., 2000, 874.
13. Y. Yoshikawa, E. Ueda, H. Miyake, H. Sakurai, and Y. Kojima, Biochem. Biophys. Res. Commun., 281, 1190 (2001).
14. Y. Yoshikawa, E. Ueda, N. Suzuki, N. Yanagihara, H. Sakurai, and Y. Kojima, Chem. Pharm. Bull., 49, 652 (2001).
15. a) Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, T. Takino, H. Sakurai, and Y. Kojima, J. Biol. Inorg. Chem., 7, 68 (2002).
16. b) Y. Yoshikawa, E. Ueda, K. Kawabe, H. Miyake, T. Takino, H. Sakurai, and Y. Kojima, J. Biol. Inorg. Chem., 7, 560 (2002).
17. Y. Kojima and H. Sakurai, PCT Patent, WO 01/39769 A1 (2001).
18. E. Ueda, Y. Yoshikawa, Y. Ishino, H. Sakurai, and Y. Kojima, Chem. Pharm. Bull., 50, 337 (2002).
19. A. Katoh, T. Tsukahara, R. Saito, K. K. Ghosh, Y. Yoshikawa, Y. Kojima, A. Tamura, and H. Sakurai, Chem. Lett., 2002, 114.
20. J. Fugono, K. Fujimoto, H. Yasui, K. Kawabe, Y. Yoshikawa, Y. Kojima, and H. Sakurai, Drug Method Pharmak., 17, 340 (2002).
21. Y. Yoshikawa, K. Kawabe, M. Tadokoro, Y. Suzuki, N. Yanagihara, A. Nakayama, H. Sakurai, and Y. Kojima, Bull. Chem. Soc. Jpn., 75, 2423 (2002).
22. Y. Yoshikawa, E. Ueda, H. Sakurai, and Y. Kojima, Chem. Pharm. Bull., 51, 652 (2003).
23. E. Mindell, "Supplement Bible," Simon & Schuster Inc., New York (1998), pp. 60-61.
24. H. Yokogoshi and M. Kobayashi, Life Sci., 62, 1065 (1998).
25. K. Sugiyama, S. Wada, and S. Saeki, Hissu Aminosan Kenkyu, 155, 67 (1999).
26. E. Ueda, Y. Yoshikawa, N. Kishimoto, M. Tadokoro, H. Sakurai, N. Kajiwara, and Y. Kojima, Bull. Chem. Soc. Jpn., in press.
27. E. Ueda, Y. Yoshikawa, N. Kishimoto, M. Tadokoro, N. Yanagihara, H. Sakurai, and Y. Kojima, Chem. Lett., 2001, 1184.
28. T. Tsushida and T. Takeo, Nippon Nogeikagaku Kaishi, 59, 787 (1985).
29. M. Nakai, H. Watanabe, C. Fujiwara, H. Kakegawa, T. Satoh, J. Takada, R. Matsushita, and H. Sakurai, Biol. Pharm. Bull., 18, 719 (1995).
30. H. Sakurai, K. Fujii, and H. Watanabe, Biochem. Biophys. Res. Commum., 214, 1995 (1995).
31. F. S. Stephens, R. S. Vagg, and P. A. Williams, Acta Crystallogr., B33, 433 (1977).
32. Y. Kojima, K. Hirotsu, T. Yamashita, and T. Miwa, Bull. Chem. Soc. Jpn., 58, 1894 (1985).
33. H. Sakurai, Y. Kojima, Y. Yoshikawa, K. Kawabe, and H. Yasui, Coord. Chem. Rev., 226, 187 (2002).
34. H. Sakurai, Chem. Rec., 2, 237 (2002).
35. Y. Yoshikawa, E. Ueda, Y. Kojima, and H. Sakurai, Life Sci., 75, 741 (2004).
36. P. Ferroni, S. Basili, A. Falco, and G. Davi, Curr. Atheroscler. Rep., 6, 424 (2004).
37. G. Zheng, K. Sayama, T. Okubo, L. R. Juneja, and I. Oguni, In Vivo, 18, 55 (2004).